Biology of the Blood-Brain and Blood-Brain Tumor Barriers

Herbert H. Engelhard, Gregory Arnone, Ankit I. Mehta, Martin K. Nicholas

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

The blood-brain barrier (BBB) provides the central nervous system (CNS) with a privileged environment by blocking entry of toxic substances, maintaining optimal concentrations of physiologic molecules, and actively eliminating unwanted substances such as metabolic by-products. The normal BBB is composed of a continuous layer of endothelial cells, constituting the luminal surface of more than 99% of the capillaries of the brain and spinal cord. These cells lack fenestrations and have high resistance tight junctions, which (along with adjacent components of the Neurovascular Unit (NVU)) greatly limit the free passage of molecules. The capillary endothelium within brain tumors has been called the "blood-brain tumor barrier." This chapter provides a general introduction to BBB-related cellular and molecular biology, physiology, and some relevant therapeutic issues. Topics discussed in this chapter include recent information related to immunology and the BBB, cerebral microdialysis, glioma stem cells, and the "BBB on a chip." While new strategies are continually being developed, the clinician's ability to administer safe and effective drugs that cross the BBB continues to be a critical issue for patients with malignant gliomas and brain micrometastases.

Original languageEnglish (US)
Title of host publicationHandbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages113-125
Number of pages13
ISBN (Print)9780128121009
DOIs
StatePublished - Apr 24 2018

Fingerprint

Blood-Brain Barrier
Brain Neoplasms
Brain
Glioma
Neoplasm Micrometastasis
Tight Junctions
Poisons
Microdialysis
Vascular Endothelium
Allergy and Immunology
Cell Biology
Molecular Biology
Spinal Cord
Stem Cells
Central Nervous System
Endothelial Cells
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Neuroscience(all)

Cite this

Engelhard, H. H., Arnone, G., Mehta, A. I., & Nicholas, M. K. (2018). Biology of the Blood-Brain and Blood-Brain Tumor Barriers. In Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition (pp. 113-125). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-812100-9.00008-5
Engelhard, Herbert H. ; Arnone, Gregory ; Mehta, Ankit I. ; Nicholas, Martin K. / Biology of the Blood-Brain and Blood-Brain Tumor Barriers. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc., 2018. pp. 113-125
@inbook{790ca69719f042b2a20340e3a46de970,
title = "Biology of the Blood-Brain and Blood-Brain Tumor Barriers",
abstract = "The blood-brain barrier (BBB) provides the central nervous system (CNS) with a privileged environment by blocking entry of toxic substances, maintaining optimal concentrations of physiologic molecules, and actively eliminating unwanted substances such as metabolic by-products. The normal BBB is composed of a continuous layer of endothelial cells, constituting the luminal surface of more than 99{\%} of the capillaries of the brain and spinal cord. These cells lack fenestrations and have high resistance tight junctions, which (along with adjacent components of the Neurovascular Unit (NVU)) greatly limit the free passage of molecules. The capillary endothelium within brain tumors has been called the {"}blood-brain tumor barrier.{"} This chapter provides a general introduction to BBB-related cellular and molecular biology, physiology, and some relevant therapeutic issues. Topics discussed in this chapter include recent information related to immunology and the BBB, cerebral microdialysis, glioma stem cells, and the {"}BBB on a chip.{"} While new strategies are continually being developed, the clinician's ability to administer safe and effective drugs that cross the BBB continues to be a critical issue for patients with malignant gliomas and brain micrometastases.",
author = "Engelhard, {Herbert H.} and Gregory Arnone and Mehta, {Ankit I.} and Nicholas, {Martin K.}",
year = "2018",
month = "4",
day = "24",
doi = "10.1016/B978-0-12-812100-9.00008-5",
language = "English (US)",
isbn = "9780128121009",
pages = "113--125",
booktitle = "Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy",
publisher = "Elsevier Inc.",
address = "United States",

}

Engelhard, HH, Arnone, G, Mehta, AI & Nicholas, MK 2018, Biology of the Blood-Brain and Blood-Brain Tumor Barriers. in Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc., pp. 113-125. https://doi.org/10.1016/B978-0-12-812100-9.00008-5

Biology of the Blood-Brain and Blood-Brain Tumor Barriers. / Engelhard, Herbert H.; Arnone, Gregory; Mehta, Ankit I.; Nicholas, Martin K.

Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc., 2018. p. 113-125.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Biology of the Blood-Brain and Blood-Brain Tumor Barriers

AU - Engelhard, Herbert H.

AU - Arnone, Gregory

AU - Mehta, Ankit I.

AU - Nicholas, Martin K.

PY - 2018/4/24

Y1 - 2018/4/24

N2 - The blood-brain barrier (BBB) provides the central nervous system (CNS) with a privileged environment by blocking entry of toxic substances, maintaining optimal concentrations of physiologic molecules, and actively eliminating unwanted substances such as metabolic by-products. The normal BBB is composed of a continuous layer of endothelial cells, constituting the luminal surface of more than 99% of the capillaries of the brain and spinal cord. These cells lack fenestrations and have high resistance tight junctions, which (along with adjacent components of the Neurovascular Unit (NVU)) greatly limit the free passage of molecules. The capillary endothelium within brain tumors has been called the "blood-brain tumor barrier." This chapter provides a general introduction to BBB-related cellular and molecular biology, physiology, and some relevant therapeutic issues. Topics discussed in this chapter include recent information related to immunology and the BBB, cerebral microdialysis, glioma stem cells, and the "BBB on a chip." While new strategies are continually being developed, the clinician's ability to administer safe and effective drugs that cross the BBB continues to be a critical issue for patients with malignant gliomas and brain micrometastases.

AB - The blood-brain barrier (BBB) provides the central nervous system (CNS) with a privileged environment by blocking entry of toxic substances, maintaining optimal concentrations of physiologic molecules, and actively eliminating unwanted substances such as metabolic by-products. The normal BBB is composed of a continuous layer of endothelial cells, constituting the luminal surface of more than 99% of the capillaries of the brain and spinal cord. These cells lack fenestrations and have high resistance tight junctions, which (along with adjacent components of the Neurovascular Unit (NVU)) greatly limit the free passage of molecules. The capillary endothelium within brain tumors has been called the "blood-brain tumor barrier." This chapter provides a general introduction to BBB-related cellular and molecular biology, physiology, and some relevant therapeutic issues. Topics discussed in this chapter include recent information related to immunology and the BBB, cerebral microdialysis, glioma stem cells, and the "BBB on a chip." While new strategies are continually being developed, the clinician's ability to administer safe and effective drugs that cross the BBB continues to be a critical issue for patients with malignant gliomas and brain micrometastases.

UR - http://www.scopus.com/inward/record.url?scp=85054691957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054691957&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-812100-9.00008-5

DO - 10.1016/B978-0-12-812100-9.00008-5

M3 - Chapter

SN - 9780128121009

SP - 113

EP - 125

BT - Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy

PB - Elsevier Inc.

ER -

Engelhard HH, Arnone G, Mehta AI, Nicholas MK. Biology of the Blood-Brain and Blood-Brain Tumor Barriers. In Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc. 2018. p. 113-125 https://doi.org/10.1016/B978-0-12-812100-9.00008-5